We recently found that chronic administration of the autophagy-inducing agent rapamycin to transgenic Tg(PrP-A116V) mice that model genetic prion disease, reduced the total load of misfolded PrP, prevented PrP amyloid plaque deposition in their brains, and significantly delayed disease onset [13]. This evidence concerns the gene PRNP and prion disease.